Dating in perimenopause can be be challenging. These are the conversations no one preps you for
Whether it's mood swings, vaginal dryness or hormonal shifts that leave you exhausted before a dinner date, these physical and emotional shifts often impact our intimacy and dating lives in ways we rarely talk about.
'Perimenopause can present with a wide range of symptoms — hot flashes, disrupted sleep, joint pain, increased anxiety,' says Dr. Mindy Goldman, an OB/GYN and chief clinical officer at Midi Health. 'And often they're unpredictable. That can absolutely impact your confidence, especially when you're dating or forming a new connection.'
That sentiment is echoed by Kiana Reeves, a certified sex educator, embodiment and intimacy coach. 'These shifts can affect how connected we feel to our bodies, which can be very intimidating when dating or being intimate with someone new,' she explains.
According to Reeves, the psychological impact is real, too: 'If we've been taught to equate youth with desirability, it can be a real reckoning. I hear from so many women who feel like they're navigating uncharted territory without a map, and often, without support.'
So if women are having trouble understanding what's going on with their bodies, how can they communicate this new phase of life to a partner? We all know communication is crucial in relationships, so having these discussions is key. But where do we even begin?
If you're not feeling as frisky as you did in your 20s or 30s and you're struggling to articulate that to a new partner, it's important to first understand why. Hormonal fluctuations — especially in estrogen, progesterone and testosterone — can have a big impact on arousal and pleasure.
'Estrogen, progesterone and testosterone all fluctuate during perimenopause, and those shifts directly affect our sexual response system,' explains Reeves. 'Many women notice that arousal takes longer, orgasms feel different or desire isn't as spontaneous. What's often misunderstood is that this doesn't mean something is wrong. Our bodies are changing, yes, but with more attention, care and the right tools, we can experience just as much — if not more — pleasure.'
I've seen women come into their sexual power in their 40s and 50s with more depth and self-possession than ever before.Kiana Reeves, sex educator
Perimenopause can also affect a woman's sense of identity and confidence. Reeves emphasizes that these changes can stir up insecurity, especially around dating or being physically vulnerable with someone new.
'Perimenopause can challenge how we've previously defined ourselves sexually,' she says. 'But it can also be a portal to something more grounded, confidence that's rooted in self-knowledge, not external validation. I've seen women come into their sexual power in their 40s and 50s with more depth and self-possession than ever before.'
Which is why having conversations with yourself about your new phase in life is effective to have before having one with a partner. Reeves recommends breathwork, gentle somatic practices and putting your hands on your body to check in.
'Self-pleasure is also a beautiful tool for staying connected to your erotic self, especially without the pressure of performing,' she adds. 'And journaling can be incredibly powerful to explore what you're feeling and where desire lives now.'
Bringing these topics up with someone you're dating can feel vulnerable. However, honesty can also help you gauge someone's capacity for empathy and emotional maturity.
'You don't need a script,' Reeves says. 'Something like, 'I've been noticing changes in my body lately and figuring out how to navigate them. I want to be open with you about it,' sets the tone for trust and mutual respect. You don't have to go into every detail right away. Just sharing that this is part of your reality can open the door to deeper connection.'
Goldman says she often talks to her patients about what it feels like to have a hot flash come on mid-conversation, or to feel completely drained during a dinner date because you were up all night tossing and turning.
'These symptoms can make you feel like you're not yourself, which can be disorienting when you're trying to be open and vulnerable with someone new.' Her advice? 'You don't have to power through in silence. Sometimes a simple, confident explanation like, 'I'm in perimenopause, and this happens sometimes,' can ease the discomfort and even deepen the conversation.'
Bringing it up lightly can even help normalize the topic. 'Sometimes saying, 'Just a hot flash — one of the perks of perimenopause!' with a smile' can ease tension, according Goldman, who adds it helps show you're not embarrassed. 'If the relationship deepens, it's OK to share more. ... A supportive partner will respect your openness, and if they don't, that's information, too. You deserve relationships where you can be fully yourself — hot flashes and all.'
Perimenopause can also change the way we feel desire and experience sex. That's something many of us don't talk about enough, especially with new partners, and starting a new romance also means finding the words to talk about it.
Reeves recommends honesty and directness, without feeling you need to share every detail: 'You can say something simple like, 'I've been noticing some changes in my body and figuring out how to navigate them. I just want to be open with you about that.' That kind of directness sets the tone for trust and mutual respect.'
Reeves also recommends using 'I' language and speaking from your own experience. 'You might say something like, 'It helps me feel more into it when we take things a little slower — can we ease into it tonight?' or, 'I really like when we stay close for a bit after; it makes me feel more connected.' Keeping it honest, affirmative and low-pressure makes it easier for your partner to respond openly, and it turns the conversation into an opportunity for deeper intimacy rather than a correction or critique.'
The goal, she says, isn't to disclose everything all at once, but to create space for curiosity and collaboration. Other scripts she recommends include:
'I've been noticing some changes in my body lately, and I'm learning how to work with them in ways that feel good. I want to be open about that as we get to know each other.'
'Things like desire and arousal look a little different for me right now, but that doesn't mean they've gone away, just that I'm learning new ways in.'
'This stage of life comes with a learning curve, and I'm figuring out what pleasure and connection look like now. I'd love to be with someone who's open to exploring that with me.'
Ultimately, if someone new is entering your life, you have the right to be met with care and curiosity, Reeves notes: 'Desire doesn't expire with age; it evolves. And a partner who's worth your time will honour the full version of you, including what you're learning and navigating in this phase.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
US pediatric group breaks with CDC advice, recommends COVID vaccines for young children
The American Academy of Pediatrics released its vaccine recommendations on Aug. 19 in a break from federal guidance shaped by Health and Human Services Secretary Robert F. Kennedy Jr. The AAP, in tandem with multiple other professional medical associations, previously decried a May announcement made by Kennedy Jr. that the COVID-19 vaccine would no longer be included in the Centers for Disease Control's recommended immunizations for healthy children and pregnant women, a move that went against previous expert guidance and bypassed the normal scientific review process. The AAP, a professional organization of over 65,000 board-certified pediatricians dedicated to advancing children's medicine, said in a June 26 statement that it would "continue to publish its own evidence-based recommendations and schedules," as the creation of federal immunization policy is 'no longer a credible process." Kennedy Jr. drew further ire from medical communities when he fired all 17 original members of the Advisory Committee on Immunization Practices, the committee of health experts that provides guidance on vaccine use to the CDC, replacing them with members that critics have called unqualified. Some of the members, like Kennedy Jr., have a history of anti-vaccine advocacy and involvement in anti-vaccine groups. Here's what to know about the new AAP guidance and how it differs from federal guidelines. What is the AAP guidance on COVID-19 vaccines for children? The AAP schedule lists which vaccines children should get at certain ages and provides updated guidance on influenza, RSV, and COVID-19 immunizations for children and adolescents from birth to age 18. The schedule recommends that all children between six months and 23 months receive the latest COVID-19 vaccine to reduce the chance of serious illness. Children and adolescents aged 2 to 18, without other high-risk factors like immunosuppression, can receive and should be offered the vaccine if they were not previously immunized, according to the guidance. Children, teens, and adults alike who are at increased risk of serious infection should receive the vaccine if they have not already, AAP said, adding that its recommendation differed from the CDC, which it said is now staffed with people who have a history of spreading vaccine misinformation. "The AAP will continue to provide recommendations for immunizations that are rooted in science and are in the best interest of the health of infants, children, and adolescents," AAP President Dr. Susan J. Kressly, MD, said in a statement. "Pediatricians know how important routine childhood immunizations are in keeping children, families and their communities healthy and thriving." What is the federal guidance on COVID-19 vaccines for children? The CDC did not go as far as completely removing COVID-19 vaccination from its immunization schedule despite Kennedy Jr.'s insistence. Instead, the agency changed its language from recommending the vaccine annually to suggesting parents consult with their child's physician on whether to vaccinate. Kennedy Jr. previously said that the CDC planned only to recommend the COVID vaccine for people over the age of 65 and those at high personal risk of infection, though the agency's website still contains information recommending it for everyone over the age of six months. A notice on the top webpages on the topic reads, "COVID-19 vaccine recommendations have recently been updated for some populations. This page will be updated to align with the updated immunization schedule," as of Aug. 19. This change to whom the vaccine is recommended could make it harder for others who want the COVID-19 vaccine to get it, experts warned. Since insurance coverage typically follows federal recommendations, anyone who wants the shot but isn't on the CDC's recommendation list may have to pay the price out of pocket HHS Communications Director Andrew Nixon defended the decision in a statement to USA TODAY, accusing the AAP, which receives funding from pharmaceutical companies like Pfizer, of failing to have proper conflict-of-interest safeguards in place. "By bypassing the CDC's advisory process and freelancing its own recommendations, while smearing those who demand accountability, the AAP is putting commercial interests ahead of public health and politics above America's children," Nixon said. Kennedy Jr. shared a separate response on social media on Aug. 19, pointing out that the agency's top donors are four companies that "make virtually every vaccine on the CDC recommended childhood vaccine schedule" and saying that the AAP recommendations are "corporate-friendly" and may "promote commercial ambitions of AAP's Big Pharma benefactors" instead of public health. "AAP should also be candid with doctors and hospitals that recommendations that diverge from the CDC's official list are not shielded from liability under the 1986 Vaccine Injury Act," his post concluded. USA TODAY reached out to AAP for comment on Aug. 19 but has not received a response. The new Advisory Committee on Immunization Practices didn't vote on COVID-19 vaccine recommendations when they met in June and are expected to reconvene in "September/October," according to the CDC. The FDA has signaled intentions to revoke the Pfizer COVID-19 shot for young, healthy children. In early August, HHS announced that it would pull $500M in funding from mRNA vaccine research and development. This article originally appeared on USA TODAY: Young kids should receive COVID vaccine despite CDC advice: AAP Solve the daily Crossword
Yahoo
39 minutes ago
- Yahoo
Boys and girls should be taught about periods together in school, academics say
Girls and boys should be taught about periods in mixed-sex groups in school to improve their understanding of menstruation, researchers have said. A study by University College London (UCL) academics has suggested that pupils in schools are being given insufficient information around periods. For many pupils they are given just two lessons about periods in their whole school career – one in primary and one in secondary, researchers have said. They have called for lessons on menstruation in schools to be much 'more comprehensive'. Since September 2020, relationships and sex education has been compulsory in secondary schools in England, while relationships education has been compulsory in primary schools. Professor Joyce Harper, from UCL Institute for Women's Health, said: 'Educating pupils about periods may now be compulsory in schools in England and Wales, but we know that for many of them that still only amounts to two lessons in their entire school career.' The researchers suggested that periods should be taught among mixed-sex groups, as well as single-sex groups, which some schools do not currently do. Prof Harper said: 'Our focus groups were also of the view that boys need to be part of that education. 'It was agreed that classes should not be segregated by gender, believing mixed sessions are crucial for boys' education. 'Although some saw value in single-sex classes to allow students to speak more freely, they still felt mixed sessions were essential to improve overall understanding. 'They suggested this could help boys understand and support their friends and future partners through menopause.' Overall, 55 women took part in the study divided into two groups based on age (18 to 25 and 26 to 40) and five focus groups were conducted for each group. They were recruited via social media, and many of the women were educated before the topic on menstruation became mandatory in English schools. The academics said menstruation is 'highly stigmatised' and a 'lack of education' about difficult periods restricts individuals from seeking help. Co-author Caroline Musulin, from UCL Institute for Women's Health, said: 'Many women endure menstrual problems longer than they should due to the inability to speak openly about uncertainties, fears of being dismissed by healthcare professionals, the view that it's 'just' a painful period or feelings of shame. 'Stigma, secrecy, and the expectation to 'cope' with painful periods contribute to the systemic dismissal of menstrual discomfort.' The latest statutory Government guidance on relationships, sex and health education (RSHE) in schools says pupils should be taught about menstruation in primary and secondary school. The guidance, which was published last month, says pupils should learn the facts about the menstrual cycle, including physical and emotional changes, by the end of primary school to help them understand what to expect. By the end of secondary school, pupils should learn about menstrual and gynaecological health – including period problems such as premenstrual syndrome, heavy menstrual bleeding, endometriosis and polycystic ovary syndrome – as well as menopause, the guidance adds. The latest Department for Education (DfE) guidance says: 'RSE lessons should ensure that both boys and girls have opportunities to practise respectful communication and understand experiences which are different from their own, including menstruation and menopause.' Schools in England will have to follow the statutory RSHE guidance from September 2026. Sarah Hannafin, head of policy for school leaders' union NAHT, said: 'Teaching about periods is a vital part of health education for all pupils. 'Although many schools may separate classes to create a safe space for discussions on topics like this, mixed-sex groups should also be planned as it is vital that pupils understand others' experiences. 'Schools need freely available high-quality resources to support them to do this. 'Education about periods needs more than a single lesson but the curriculum in both primary and secondary schools is overcrowded and the new RSHE guidance has added a lot of new content without any additional time being created.' Pepe Di'Iasio, general secretary of the Association of School and College Leaders, said: 'We fully support the need for boys and girls to be taught about menstruation in a comprehensive manner which goes beyond biological facts and covers the wider effects on wellbeing. 'It is essential to be able to discuss this topic openly without misinformation or embarrassment. 'While it is covered in the RSHE curriculum we would welcome consideration of how teaching of this topic might be strengthened.' A DfE spokesperson said: 'Understanding menstruation is an important part of growing up, which is why we have brought in a new relationships, sex and health education curriculum to take effect next year, with clear guidance that pupils should be taught about both physical and emotional changes, as well as topics from endometriosis to heavy menstrual bleeding. 'As part of our plan for change, we're providing teachers with new resources to help them run great lessons on these issues, tackle stigma head-on and support every child to achieve and thrive.'
Yahoo
39 minutes ago
- Yahoo
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies
CAMBRIDGE, Mass., Aug. 19, 2025 /PRNewswire/ -- XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop therapeutics for immunological and inflammatory diseases. This collaboration will be based on XtalPi's intelligent and automated drug discovery platform, which integrates artificial intelligence (AI), quantum physics, and large-scale automated robotic experiments. The two companies plan to co-identify targets and discover first-in-class or best-in-class drug candidates using XtalPi's proprietary AI-driven drug discovery platform. The XtalPi platform combines the speed and generative power of AI with the accuracy of its robotic lab-in-the-loop to accelerate drug discovery and vastly expand the explorable chemical space. This integrated workflow spans deep-learning-based molecule design, quantum physics and molecular dynamics simulations for predicting drug-target interactions, automated chemical synthesis, and experimental validation of candidate compounds' key pharmaceutical properties. Leveraging its expertise in immunology and inflammation as well as its experience in small molecule drug development, Dong-A ST will actively participate throughout the entire R&D process—including candidate validation, efficacy and safety testing, and the formulation of preclinical and clinical development strategies. The company also plans to explore strategies for pipeline expansion and assess commercialization potential. Through this partnership, Dong-A ST aims to strengthen its pipeline in the immunology and inflammation space and expand its R&D scope beyond small molecule therapeutics into areas such as targeted protein degradation (TPD), biologics, antibody-drug conjugates (ADC), and gene therapies. John Wang, Senior Vice President of Drug Discovery at XtalPi, stated: "The combination of Dong-A ST's extensive expertise and XtalPi's proven AI-robotics platform is well-positioned to translate scientific innovation into competitive precision medicines. Together, we aim to rapidly discover and rigorously validate novel drug candidates across multiple modalities to unlock unique market opportunities, and deliver transformative therapies for global patients." Jae-Hong Park, Head of R&D at Dong-A ST, remarked, "This collaboration marks a pivotal step in expanding Dong-A ST's R&D capabilities," adding, "By leveraging synergies with XtalPi's AI platform, we expect to accelerate the development of next-generation treatments for immune and inflammatory diseases." Meanwhile, both Dong-A ST and XtalPi operate open innovation offices in Boston, USA. This geographic proximity will facilitate closer and more efficient collaboration throughout the drug discovery process. About Dong-A ST Dong-A ST Co., Ltd. ( was established in 1932 and is a leading Korean pharmaceutical company engaged in the development, manufacturing, and commercialization of ethical drugs, biosimilars, medical devices, and diagnostics. Its key products include Stillen (gastritis), Zydena (erectile dysfunction), Motilitone (functional dyspepsia), and Imuldosa (ustekinuma biosimilar). Leveraging strong R&D capabilities and a history of innovation, Dong-A ST is expanding its pipeline in immunology, inflammation, neurological disease, metabolic diseases, and oncology, while advancing into new modalities such as biologics, ADCs, TPD, and gene therapies. About XtalPi XtalPi Holdings Limited (XtalPi, was founded in 2015 by three physicists from the Massachusetts Institute of Technology (MIT). It is an innovative R&D platform powered by quantum physics, artificial intelligence, and robotics. By integrating first-principles calculations, AI algorithms, high-performance cloud computing, and standardized automation systems, XtalPi provides digital and intelligent R&D solutions for companies in the pharmaceutical, materials science, agricultural technology, energy, new chemicals, and cosmetics industries. View original content to download multimedia: SOURCE XtalPi Inc. Sign in to access your portfolio



